Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

NCT02081326 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02081326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02081326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 30, 2015
Completion date
July 31, 2031
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diabetes, covid19, diabetes mellitus, type i, diabetes mellitus, type one